A Suite Of Solutions To Support Respiratory Care and Drug Development.
AireHealth provides digital health solutions that can be used to support new or existing remote monitoring programs, virtual clinical trials and respiratory drug development. Our home-based respiratory care platform combines effective and efficient drug delivery with actionable clinical data, to provide early detection of respiratory decline, improve care outcomes, and reduce costs.
We’d love to tell you more about AireHealth’s digital health solution.
Value Of Remote Patient Monitoring
A recent clinical study supports the use of remote patient monitoring (RPM) programs to guide appropriate interventions aimed at reducing healthcare utilization in COPD patients.
Cooper, C. et al. Remote Patient Monitoring for the Detection of COPD Exacerbations. Int J Chron Obstruct Pulmon Dis. 2020; 15: 2005–2013.
Building Blocks of Our Respiratory Digital Platform
Remote Therapeutic Monitoring
The Centers for Medicare and Medicaid Services (CMS) reimbursement policies and other regulations have helped fuel the rapid adoption of remote patient monitoring (RPM).
Recently, CMS released its proposed Medicare Physician Fee Schedule for Calendar Year 2022. In doing so, it recognized five new CPT codes for Remote Therapeutic Monitoring (“RTM”) of “non-physiologic” patient data such as “musculoskeletal system status, respiratory system status, therapy (medication) adherence, and therapy (medication) response.
The AireHealth Difference
FDA cleared, class II HIPAA-compliant medical device. Portable, battery operated, and ergonomically designed to enables patients to complete their respiratory treatments any place, any time.
Innovative bluetooth-enabled nebulizer and MyAireHealth app empowers patients and their loved ones to track medication adherence, set-up treatment reminders, report symptom exacerbations, and connect with their care teams.
Cloud-based API easily integrates into existing RPM provider portals to track medication adherence and report patient use data to clinicians in near real-time.
Tunable mesh enables size and shape of droplets to be adjusted to accommodate different and novel drugs.
We Are Revolutionizing Respiratory Care
As an innovative digital health company, delivering meaningful innovation is our passion. With strong IP and clinically validated products in our pipeline, we enable more personalized medicine, proactive care, and early interventions to improve outcomes and reduce costs. Our senior management team has 150+ years combined experience developing, commercializing and launching medical technology products globally.